Ac- Pro-His-Ser-Cys-Asn-NH2,
Ac-PHSCN-NH2,
acetyl-prolyl-histidyl-seryl-cysteinyl-asparaginamide,
ATN-161,
262438-43-7,
ATN 161,
UNII-XW0H5LE42K,
XW0H5LE42K,
SCHEMBL2157375,
SCHEMBL17262996,
AOB2958,
DTXSID60180877,
ZINC3924034,
ATN-161 (Ac-PHSCN-NH2),
s8454,
AKOS030210988,
CS-3327,
HY-13535,
Acetyl-prolyl-histidyl-seryl-cysteinyl-asparaginamide,
L-Aspartamide, 1-acetyl-L-prolyl-L-histidyl-L-seryl-L-cysteinyl-,
PHSCN,
D00QVT,
PHSCN, University of Michigan,
CID9960285,
Ac-PHSCN-NH2, University of Michigan,
CID 9960285,
Integrin antagonists (cancer), Attenuon,
Angiogenesis inhibitors (cancer), Attenuon,